Skip to content
★ Sign in to follow
PA

Peter A. Zorn

Executive
Albireo Pharma, Inc.Gyre Therapeutics, Inc.
Total declarations
20
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€1.9M

Latest filing published 07 Nov 2016 for Albireo Pharma, INC..

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

No signal scores available.

Peter A. Zorn: trading record in brief

Peter A. Zorn has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Gyre Therapeutics, Inc. and Albireo Pharma, Inc. The record holds 20 filings, for trades running from 19 October 2009 to 3 November 2016.

The open-market record consists of 7 sales worth €1.9M, with no purchase. The rest of the record consists of 1 share grant and 12 option exercises.

The record was last updated on 7 November 2016 with a share grant in Albireo Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Peter A. Zorn

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations20 total

20 of 20 declarations